Entecavir

Product manufactured by Cipla Usa Inc.

Application Nr Approved Date Route Status External Links
ANDA206872 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Entecavir Tablet Is A Hepatitis B Virus Nucleoside Analogue Reverse Transcriptase Inhibitor Indicated For The Treatment Of Chronic Hepatitis B Virus Infection In Adults And Children At Least 2 Years Of Age With Evidence Of Active Viral Replication And Either Evidence Of Persistent Elevations In Serum Aminotransferases (Alt Or Ast) Or Histologically Active Disease. ( 1 ) Entecavir Tablet Is Indicated For The Treatment Of Chronic Hepatitis B Virus Infection In Adults And Pediatric Patients 2 Years Of Age And Older With Evidence Of Active Viral Replication And Either Evidence Of Persistent Elevations In Serum Aminotransferases (Alt Or Ast) Or Histologically Active Disease.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Entecavir ENTECAVIR ZINC3802690

Comments